Regencell Bioscience (RGC)
(Real Time Quote from BATS)
$6.75 USD
-0.85 (-11.18%)
Updated Aug 5, 2024 12:44 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
RGC 6.75 -0.85(-11.18%)
Will RGC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RGC based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for RGC
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Regencell Bioscience Holdings Ltd trading resumes
Regencell Bioscience Holdings Ltd trading halted, volatility trading pause
Catalyst Watch: Tech blitz with Apple, Amazon, Microsoft, and Meta on tap for earnings